/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

style
pb-0

Illumina Inc.

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0
$127.95 0.0031(0.31%) ILMN at 04 Dec 2025 04:35 PM Diagnostics & Research
Lowest Today 127.52
Highest Today 129.64
Today’s Open 127.9
Prev. Close 127.55
52 Week High 153.06
52 Week Low 68.70
Day’s Range: Low 127.52 High 129.64
52-Week Range: Low 68.70 High 153.06
1 day return -
1 Week return -2.67
1 month return +9.44
3 month return +30.98
6 month return +53.8
1 year return -10.21
3 year return -40.21
5 year return -63.54
10 year return -

Institutional Holdings

BlackRock Inc 12.59

Capital World Investors 10.83

Vanguard Group Inc 9.86

State Street Corp 3.65

iShares Core S&P Mid-Cap ETF 3.35

American Funds Growth Fund of Amer A 3.28

Capital Group Growth Fnd of Amer Comp 3.28

Vanguard Total Stock Mkt Idx Inv 3.08

Sessa Capital IM LP 3.07

WCM Investment Management 2.88

Loomis, Sayles & Company LP 2.75

Corvex Management LP 2.49

Vanguard Small Cap Index 2.38

AQR Capital Management LLC 2.14

PointState Capital LP 1.92

Geode Capital Management, LLC 1.87

Vanguard Small Cap Value Index Inv 1.53

Bank of New York Mellon Corp 1.52

American Funds American Balanced A 1.45

GuardCap Asset Management Limited 1.33

American Funds New Perspective A 1.30

Capital Group New Perspective Comp 1.30

PRIMECAP Management Company 1.27

Bank of America Corp 1.26

HHG PLC 1.25

UBS Asset Mgmt Americas Inc 1.17

Baillie Gifford & Co Limited. 1.13

Vanguard Institutional Extnd Mkt Idx Tr 1.11

Northern Trust Corp 1.04

Edmond de Rothschild Holding S.A. 0.93

American Funds Washington Mutual A 0.89

Capital Group Wash Mutual Invtrs Comp 0.89

American Funds New Economy A 0.89

Capital Group New Economy Comp 0.89

American Funds IS® Growth 1 0.88

Capital Group Growth Composite 0.88

Janus Henderson Enterprise D 0.82

Janus Inst Mid Cap Growth CF 0.82

SPDR® S&P MIDCAP 400 ETF Trust 0.79

Capital Group Fundamental Invtrs Comp 0.76

Market Status

Strong Buy: 7

Buy: 5

Hold: 11

Sell: 2

Strong Sell: 0

Fundamentals

Market Cap 19604.43 M

PB Ratio 8.2606

PE Ratio 28.6629

Enterprise Value 20966.42 M

Total Assets 6303.00 M

Volume 831631

Company Financials

Annual Revenue FY24:4372000000 4372.0M, FY23:4504000000 4504.0M, FY22:4584000000 4584.0M, FY21:4526000000 4526.0M, FY20:3239000000 3239.0M

Annual Profit FY24:2861000000 2861.0M, FY23:2744000000 2744.0M, FY22:2972000000 2972.0M, FY21:3154000000 3154.0M, FY20:2203000000 2203.0M

Annual Net worth FY24:-1223000000 -1223.0M, FY23:-1161000000 -1161.0M, FY22:-4404000000 -4404.0M, FY21:762000000 762.0M, FY20:656000000 656.0M

Quarterly Revenue Q3/2025:1083000000 1083.0M, Q2/2025:1059000000 1059.0M, Q1/2025:1041000000 1041.0M, Q4/2024:1104000000 1104.0M, Q3/2024:1080000000 1080.0M

Quarterly Profit Q3/2025:732000000 732.0M, Q2/2025:695000000 695.0M, Q1/2025:683000000 683.0M, Q4/2024:728000000 728.0M, Q3/2024:745000000 745.0M

Quarterly Net worth Q3/2025:150000000 150.0M, Q2/2025:235000000 235.0M, Q1/2025:131000000 131.0M, Q4/2024:187000000 187.0M, Q3/2024:705000000 705.0M

Fund house & investment objective

Company Information Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.

Organisation Diagnostics & Research

Employees 8970

Industry Diagnostics & Research

CEO Mr. Jacob Thaysen Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow